secwatch.observer — SEC 8-K summary
======================================

Issuer:     IonQ, Inc. (IONQ)
CIK:        0001824920
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0000950170-24-122264
Event type: earnings
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IonQ beats Q3 with $12.4M rev (+102% YoY), raises FY guide; $63.5M bookings; agrees to buy Qubitekk
--------------------------------------------------------------------------------

- Q3 revenue $12.4M (above guidance high end), +102% YoY from $6.1M.
- Full-year 2024 revenue guidance raised to $38.5M-$42.5M.
- Q3 bookings $63.5M, including largest U.S. quantum contract of $54.5M from AFRL.
- Definitive agreement to acquire Qubitekk, a quantum networking company.
- Partnerships with AstraZeneca (drug discovery), Ansys (CAE), and Univ. of Maryland.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824920/000095017024122264/0000950170-24-122264-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824920/000095017024122264/ionq-20241106.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-122264

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer